229 studies found for:    "Mesothelioma"
Show Display Options
Rank Status Study
21 Completed Capecitabine in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: capecitabine
22 Completed SU5416 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: semaxanib
23 Completed
Has Results
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: pemetrexed disodium;   Drug: gemcitabine hydrochloride;   Drug: carboplatin
24 Completed Serum Biomarkers in Diagnosis of Mesothelioma
Condition: Mesothelioma
Intervention: Biological: Mesothelin, hyaluronan, osteopontin, syndecan-1
25 Unknown  Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Biological: PA-1-STK ovarian carcinoma vaccine;   Drug: ganciclovir
26 Completed
Has Results
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: dasatinib
27 Completed
Has Results
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Recurrent Malignant Mesothelioma
Intervention: Drug: sunitinib malate
28 Completed PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: vatalanib
29 Completed Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib;   Procedure: quality-of-life assessment
30 Completed Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
Condition: Malignant Mesothelioma
Intervention: Drug: raltitrexed
31 Completed Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Procedure: conventional surgery
32 Unknown  Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
Conditions: Lung Cancer;   Mesothelioma
Intervention:
33 Unknown  Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: methotrexate;   Drug: vinorelbine ditartrate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
34 Completed Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: epirubicin hydrochloride;   Drug: gemcitabine hydrochloride
35 Recruiting Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
Conditions: Mesothelioma;   Lung Cancer
Intervention:
36 Completed Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: bevacizumab;   Drug: cisplatin;   Drug: pemetrexed
37 Completed Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Procedure: adjuvant therapy;   Procedure: conventional surgery;   Drug: porfimer sodium
38 Completed Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma;   Metastatic Cancer
Interventions: Other: talc;   Procedure: therapeutic thoracoscopy;   Procedure: therapeutic videothoracoscopy
39 Recruiting SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Pentostatin;   Drug: Cyclophosphamide;   Drug: SS1P
40 Completed Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
Condition: Malignant Mesothelioma
Interventions: Other: immunoenzyme technique;   Other: laboratory biomarker analysis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years